HealthCor Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,910
Closed -$17.7M 38
2022
Q3
$17.7M Sell
38,910
-15,320
-28% -$7.33M 2.21% 18
2022
Q2
$26.2M Sell
54,230
-19,120
-26% -$9.46M 2.63% 13
2022
Q1
$36M Sell
73,350
-28,210
-28% -$12.9M 2.4% 20
2021
Q4
$47.1M Buy
+101,560
New +$42.7M 2.56% 14
2021
Q2
Sell
-91,760
Closed -$32.9M 86
2021
Q1
$32.9M Buy
+91,760
New +$29.5M 1.17% 31
2019
Q3
Sell
-151,220
Closed -$42.7M 61
2019
Q2
$42.7M Buy
+151,220
New +$41.3M 1.66% 24
2018
Q4
Sell
-304,270
Closed -$83.4M 43
2018
Q3
$83.4M Sell
304,270
-370,730
-55% -$96.2M 2.77% 16
2018
Q2
$161M Buy
675,000
+406,230
+151% +$94.1M 5.1% 5
2018
Q1
$59M Sell
268,770
-47,410
-15% -$11.1M 2.01% 17
2017
Q4
$71.1M Buy
+316,180
New +$67.3M 2.32% 20
2013
Q4
Sell
-175,000
Closed -$14.6M 58
2013
Q3
$14.6M Buy
+175,000
New +$15M 0.78% 38

Other funds holding ELV

HealthCor Management's ELV Position: Q4 2022 in Review

HealthCor Management sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 38,910 shares — an estimated $17.7M sold.

HealthCor Management first reported a position in ELV in Q3 2013 and held it in 11 quarters. The position peaked at $161M in Q2 2018. 1,549 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • HealthCor Management reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • HealthCor Management sold 38,910 Elevance Health shares in Q4 2022, an estimated $17.7M.
  • HealthCor Management first reported a position in Elevance Health in Q3 2013 and held it in 11 quarters.
  • HealthCor Management's Elevance Health position peaked at $161M in Q2 2018.
  • 1,549 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.